Overview

Update
IPO / Stock
Went Public on Mar 28, 2012 / NASDAQ:DBVT
Total Equity Funding
$28.2M in 2 Rounds from 5 Investors
Headquarters:
Bagneux
Description:
DBV Technologies focuses on the development of innovative products for the diagnosis and treatment of food allergies.
Founders:
,
Categories:
Health Care, Biotechnology, Health Diagnostics
Website:
http://www.dbv-technologies.com
Social:

Funding Rounds (2) - $28.2M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jan, 2011$25.5M / Series C5
Dec, 2010$2.7M / Venture0

Current Team (4)

Update

Board Members and Advisors (3)

Update

Offices/Locations (1)

Update
  • Office

    Batiment D 80/84 rue des Meuniers

    Green Square

    Bagneux, 92220

    FRA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos